A new paradigm in cancer treatment – combining the effectiveness of targeted therapy and immunotherapy

A new paradigm in cancer treatment – combining the effectiveness of targeted therapy and immunotherapy

Press Releases

Oxford, UK, 26th November 2015 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced that it will be giving a poster presentation at the 57th ASH Annual Meeting, Orlando, USA.

The poster presentation is entitled “Design and Development of a Novel Orally-Active, PI3K-p110Beta/Delta Inhibitor with Combined Tumor Immunotherapeutic, Growth Inhibition and Anti-Metastatic Activity” and will take place on Saturday, December 5, 2015, 5:30 PM-7:30 PM, Hall A, Level 2 (Orange County Convention Center).

For more information on Karus’s presentations or for media enquiries, please contact karus@instinctif.com.